FDA Consent Decree Compliance & Support

An FDA consent decree is a court-enforced agreement used when the agency identifies serious or ongoing compliance failures. It typically requires a company to stop certain operations, complete specific remediation activities, submit to independent oversight, and demonstrate sustained compliance before normal operations can fully resume. It is one of FDA's most serious enforcement tools.

An FDA consultant helps companies understand regulatory requirements, assess compliance gaps, prepare submissions, respond to agency actions, and strengthen quality systems. In a consent decree context, consultants often support remediation planning, CAPA execution, documentation upgrades, internal audits, training, inspection readiness, and communication strategies that help organizations meet FDA expectations more effectively.

Most organizations need structured support across gap assessment, remediation planning, quality system correction, documentation updates, training, internal audits, and ongoing oversight. They may also need help with CAPA governance, complaint handling, design control remediation, and preparing evidence that corrective actions are effective, sustainable, and aligned with decree obligations and FDA expectations.

Remediation timelines vary based on the scope of deficiencies, the maturity of the quality system, and the resources available for execution. Many programs take months or longer because FDA expects not only corrected procedures, but also objective evidence that the new controls are implemented, effective, and sustained across operations, records, and management oversight.

Yes. Elexes provides internal audits designed to identify unresolved gaps, verify corrective action progress, and assess whether systems are operating as intended. These audits can cover QMS processes, complaint handling, CAPA, design controls, training, and documentation practices, giving leadership a clearer view of readiness before FDA follow-up or independent review.

Critical documents often include CAPA records, SOPs, training records, complaint files, audit reports, management review outputs, risk management files, design history files, validation records, and evidence of implementation. FDA and oversight bodies typically look for consistency between procedures, actual practice, and objective records that show corrective actions are complete and effective.

Progress is usually measured through milestone completion, closure of identified gaps, audit outcomes, training completion, CAPA effectiveness checks, documentation quality, and evidence that revised processes are being followed consistently. Strong remediation programs also track overdue actions, recurring issues, and management review metrics to confirm that improvements are sustained rather than temporary.

Yes. Outsourced RAQA support can provide experienced regulatory and quality leadership without requiring immediate internal hiring. This is especially valuable when a company needs rapid execution across documentation control, audit readiness, complaint governance, CAPA administration, and regulatory response. An embedded external team can also help maintain momentum while internal resources are stretched.